Results 211 to 220 of about 29,085 (240)
Multifunctional gold nanoparticles: bridging detection, diagnosis, and targeted therapy in cancer. [PDF]
Zhuang L, Lian Y, Zhu T.
europepmc +1 more source
Mesoporous silica nanoparticles--based functional platforms for breast cancer therapy: technological advancements. [PDF]
Du Y, Yang J, Chen S, Fu D.
europepmc +1 more source
1,3,4-Oxadiazole derivatives: targeting multiple bacterial pathways. [PDF]
Gupta P +5 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The Reduced Folate Carrier Gene Is a Novel Selectable Marker for Recombinant Protein Overexpression
Molecular Pharmacology, 2005Folate cofactors are one-carbon donors essential for the biosynthesis of purines and thymidylate. Mammalian cells are devoid of folate biosynthesis and are therefore folate auxotrophs that take up folate vitamins primarily via the reduced folate carrier (RFC).
Rothem, Lilah +4 more
openaire +3 more sources
1993
The role of membrane transport is an important parameter in the biological evaluation of novel antifolates.1–3 In this respect the reduced folate/methotrexate carrier (RFC) is considered to be the major transport route for these compounds in neoplastic cells.4 However, there is accumulating evidence that other transport routes for (anti)folates may be ...
Jansen, G +4 more
openaire +4 more sources
The role of membrane transport is an important parameter in the biological evaluation of novel antifolates.1–3 In this respect the reduced folate/methotrexate carrier (RFC) is considered to be the major transport route for these compounds in neoplastic cells.4 However, there is accumulating evidence that other transport routes for (anti)folates may be ...
Jansen, G +4 more
openaire +4 more sources
Drug Metabolism and Disposition
Antifolates are important for chemotherapy in non-small cell lung cancer (NSCLC). They mainly rely on reduced folate carrier (RFC) and proton-coupled folate transporter (PCFT) to enter cells. PCFT is supposed to be the dominant transporter of the two in tumors, as it operates optimally at acidic pH and has limited transport activity at physiological pH,
Yuqing Wang +8 more
openaire +2 more sources
Antifolates are important for chemotherapy in non-small cell lung cancer (NSCLC). They mainly rely on reduced folate carrier (RFC) and proton-coupled folate transporter (PCFT) to enter cells. PCFT is supposed to be the dominant transporter of the two in tumors, as it operates optimally at acidic pH and has limited transport activity at physiological pH,
Yuqing Wang +8 more
openaire +2 more sources
Cancer research, 2001
IgG polyclonal antiserum was generated in New Zealand White rabbits immunized with a 16-mer peptide consisting of a specific amino acid sequence at residues corresponding to the sixth to seventh predicted transmembrane domain of the human reduced folate carrier (RFC).
T M, Trippett +6 more
openaire +1 more source
IgG polyclonal antiserum was generated in New Zealand White rabbits immunized with a 16-mer peptide consisting of a specific amino acid sequence at residues corresponding to the sixth to seventh predicted transmembrane domain of the human reduced folate carrier (RFC).
T M, Trippett +6 more
openaire +1 more source

